Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

Ability to treat diabetic patients: DES + DCB strategy

23 May 2019 – From EuroPCR 2019

Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.

Ability to treat diabetic patients: DES + DCB strategy

Complex stenting optimised by intracoronary imaging

23 May 2019 – From EuroPCR 2019

Consult this session on intracoronary imaging for complex stenting to learn how to recognise image findings which may impact on stent strategy and results, how to react to imaging for complex stent optimisation and how to optimally guide interventions during bailout situations.

Complex stenting optimised by intracoronary imaging

Exploring evidence and experience with magnesium scaffold Magmaris

23 May 2019 – From EuroPCR 2019

Consult this session on magnesium scaffold Magmaris to learn more about the available data on its clinical use and to review interesting intravascular imaging data after Magmaris implantation.

Exploring evidence and experience with magnesium scaffold Magmaris

New trials in coronary imaging and physiology

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the new trials and studies in coronary imaging and physiology: FFR-Search, ROCK II, HAWKEYE, and more!

New trials in coronary imaging and physiology

Latest clinical and technology update of Firehawk Target eluting stent platform

23 May 2019 – From EuroPCR 2019

Consult this session to discover all about the latest clinical and technology update of Firehawk Target eluting stent platform, the results and insights of Target AC trial 2-year follow-up, and more!

Latest clinical and technology update of Firehawk Target eluting stent platform

Crushed, dislodged and compressed: features of complicated stent deployment - Part 2

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about the features of complicated stent deployment and how to efficiently manage this procedure.

Crushed, dislodged and compressed: features of complicated stent deployment - Part 2

Stent dislodgement still happens! - Part 3

23 May 2019 – From EuroPCR 2019

Consult this session to learn through various clinical cases how to efficiently manage stent dislodgment in complex situations.

Stent dislodgement still happens! - Part 3

Optimising the treatment of severely calcified vessels with orbital atherectomy

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to use orbital atherectomy for lesion preparation, enabling successful stent delivery, expansion and apposition and how the use of advanced imaging and the Diamondback 360 coronary orbital atherectomy system can optimise PCI outcomes.

Optimising the treatment of severely calcified vessels with orbital atherectomy

Stent thrombosis: what's next?

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about stent thrombosis, and discover how to identify, prevent, and manage this complication, particularly in patients with STEMI.

Stent thrombosis: what's next?

Trials and registries - Managing bleeding risk in search of optimal drug-device synergy

23 May 2019 – From EuroPCR 2019

Consult this session to discover the results of the latest trials and registries for the management of bleeding risk in search of optimal drug-device synergy: ROBOT-ACS, GLOBAL LEADERS, SAFE-A, and more!

Trials and registries - Managing bleeding risk in search of optimal drug-device synergy